Literature DB >> 18430388

Bone biopsy in patients with osteoporosis.

Hartmut H Malluche1, Hanna Mawad, Marie-Claude Monier-Faugere.   

Abstract

Although rarely used to diagnose and manage patients with osteoporosis, bone biopsies are performed to establish bone quality, including degree of mineralization and microarchitecture; to assess bone turnover and bone loss mechanisms; and to analyze treatment effects on bone structure and bone turnover. Bone biopsies are also the only method to diagnose mineralization defect or frank osteomalacia. Due to the availability of antiresorptive agents and anabolic drugs, determining bone turnover and bone-loss mechanisms is critical to appropriate treatment regimen selection. Bone biopsies establish the safety and efficacy of new therapeutic modalities. Further, new techniques such as molecular morphometry (in situ hybridization and immunohistochemistry) and analysis of bone content and crystal perfection have been applied to undecalcified bone and elucidated pathogenetic mechanisms or abnormalities in bone microstructure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18430388     DOI: 10.1007/s11914-007-0009-x

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  27 in total

1.  Percutaneous biopsy of the iliac crest.

Authors:  K A Johnson; P J Kelly; J Jowsey
Journal:  Clin Orthop Relat Res       Date:  1977 Mar-Apr       Impact factor: 4.176

2.  Structural and cellular assessment of bone quality of proximal femur.

Authors:  L D Dorr; M C Faugere; A M Mackel; T A Gruen; B Bognar; H H Malluche
Journal:  Bone       Date:  1993 May-Jun       Impact factor: 4.398

3.  Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age.

Authors:  P Lips; P Courpron; P J Meunier
Journal:  Calcif Tissue Res       Date:  1978-11-10

4.  Five-year postoperative results of cemented femoral arthroplasty in patients with systemic bone disease.

Authors:  L D Dorr; I Arnala; M C Faugere; H H Malluche
Journal:  Clin Orthop Relat Res       Date:  1990-10       Impact factor: 4.176

5.  In situ investigation of vitamin D receptor, alkaline phosphatase, and osteocalcin gene expression in oro-facial mineralized tissues.

Authors:  J L Davideau; P Papagerakis; D Hotton; F Lezot; A Berdal
Journal:  Endocrinology       Date:  1996-08       Impact factor: 4.736

6.  Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.

Authors:  H G Bone; S L Greenspan; C McKeever; N Bell; M Davidson; R W Downs; R Emkey; P J Meunier; S S Miller; A L Mulloy; R R Recker; S R Weiss; N Heyden; T Musliner; S Suryawanshi; A J Yates; A Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

7.  Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients.

Authors:  Robert Recker; Joan Lappe; K Michael Davies; Robert Heaney
Journal:  J Bone Miner Res       Date:  2004-07-21       Impact factor: 6.741

8.  Bone changes occurring early after cessation of ovarian function in beagle dogs: a histomorphometric study employing sequential biopsies.

Authors:  M C Faugere; R M Friedler; P Fanti; H H Malluche
Journal:  J Bone Miner Res       Date:  1990-03       Impact factor: 6.741

9.  Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study.

Authors:  R R Recker; R S Weinstein; C H Chesnut; R C Schimmer; P Mahoney; C Hughes; B Bonvoisin; P J Meunier
Journal:  Osteoporos Int       Date:  2004-01-16       Impact factor: 4.507

10.  Age-related reduction in bone matrix protein mRNA expression in rat bone tissues: application of histomorphometry to in situ hybridization.

Authors:  T Ikeda; Y Nagai; A Yamaguchi; S Yokose; S Yoshiki
Journal:  Bone       Date:  1995-01       Impact factor: 4.398

View more
  8 in total

1.  Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients.

Authors:  Aluizio Barbosa Carvalho; Ricardo Carneiro; Graziella M Leme; Carlos E Rochitte; Raul D Santos; Márcio H Miname; Rosa M Moyses; Vanda Jorgetti; Maria Eugênia F Canziani
Journal:  J Bone Miner Metab       Date:  2013-03-21       Impact factor: 2.626

Review 2.  Quantitative imaging methods in osteoporosis.

Authors:  Ling Oei; Fjorda Koromani; Fernando Rivadeneira; M Carola Zillikens; Edwin H G Oei
Journal:  Quant Imaging Med Surg       Date:  2016-12

Review 3.  Management of Osteoporosis and Spinal Fractures: Contemporary Guidelines and Evolving Paradigms.

Authors:  Nasvin Imamudeen; Amjad Basheer; Anoop Mohamed Iqbal; Nihal Manjila; Nisha Nigil Haroon; Sunil Manjila
Journal:  Clin Med Res       Date:  2022-04-27

4.  Young's modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years.

Authors:  D Pienkowski; C L Wood; H H Malluche
Journal:  Osteoporos Int       Date:  2018-11-28       Impact factor: 4.507

5.  Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates.

Authors:  J Ward; C Wood; K Rouch; D Pienkowski; H H Malluche
Journal:  Osteoporos Int       Date:  2016-07-22       Impact factor: 4.507

6.  Low bone mineral density due to secondary hyperparathyroidism in the GlatmTg(CAG-A4GALT) mouse model of Fabry disease.

Authors:  Hiroki Maruyama; Atsumi Taguchi; Mariko Mikame; Hongmei Lu; Norihiro Tada; Muneaki Ishijima; Haruka Kaneko; Mariko Kawai; Sawako Goto; Akihiko Saito; Riuko Ohashi; Yuji Nishikawa; Satoshi Ishii
Journal:  FASEB Bioadv       Date:  2020-06-10

Review 7.  Bone Phenotyping Approaches in Human, Mice and Zebrafish - Expert Overview of the EU Cost Action GEMSTONE ("GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork").

Authors:  Ines Foessl; J H Duncan Bassett; Åshild Bjørnerem; Björn Busse; Ângelo Calado; Pascale Chavassieux; Maria Christou; Eleni Douni; Imke A K Fiedler; João Eurico Fonseca; Eva Hassler; Wolfgang Högler; Erika Kague; David Karasik; Patricia Khashayar; Bente L Langdahl; Victoria D Leitch; Philippe Lopes; Georgios Markozannes; Fiona E A McGuigan; Carolina Medina-Gomez; Evangelia Ntzani; Ling Oei; Claes Ohlsson; Pawel Szulc; Jonathan H Tobias; Katerina Trajanoska; Şansın Tuzun; Amina Valjevac; Bert van Rietbergen; Graham R Williams; Tatjana Zekic; Fernando Rivadeneira; Barbara Obermayer-Pietsch
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-01       Impact factor: 5.555

8.  Educational Case: Osteoporosis.

Authors:  Jonathan Light; Harrison Klause; Richard M Conran
Journal:  Acad Pathol       Date:  2022-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.